← Eichor
Condition: Immune Mediated Diseases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Immune Mediated Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
Phase 2 · 37 location(s) · RAPT Therapeutics, Inc. · NCT07220811Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-medi
Phase N/A · 4 location(s) · Meyer Children's Hospital IRCCS · NCT06862843IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies
Phase 2 · 1 location(s) · Endeavor Health · NCT04153422An Exploratory Clinical Study on the Safety and Efficacy of Anti-CD19/BCMA U CAR-T Cells in the Treatment of Relapsed/Re
EARLY_Phase 1 · 1 location(s) · Changhai Hospital · NCT07241468PET-Based Imaging of Radiolabeled CIT-013
Phase 2 · 1 location(s) · Citryll BV · NCT07147959Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07513948Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06899789Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Phase 2 · 8 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07103746Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development
Phase N/A · 3 location(s) · Fundació Sant Joan de Déu · NCT07033663Effectiveness and Safety of Milk Ladders in Children with IgE-Mediated Cow's Milk Protein Allergy
NA · 2 location(s) · Medical University of Warsaw · NCT06664918Specific Oral Tolerance Induction (SOTI) to Children With IgE-mediated Wheat Allergy
Phase N/A · 1 location(s) · Athens General Children's Hospital "Pan. & Aglaia Kyriakou" · NCT03352193CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07305116Deployment o the Multidisciplinary Prospective Cohort Imminent
NA · 1 location(s) · University Hospital, Lille · NCT04334031A Prospective Sub-Study of the Global Hypophosphatasia Registry
Phase N/A · 12 location(s) · Alexion Pharmaceuticals, Inc. · NCT05234567A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
Phase 3 · 11 location(s) · Regeneron Pharmaceuticals · NCT07112378This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
Phase 2 · 1 location(s) · University of California, San Francisco · NCT06853223Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · 131 location(s) · Novartis Pharmaceuticals · NCT05755386Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms
Phase N/A · 1 location(s) · Universidad Politecnica de Madrid · NCT05681975Evaluation of the Tolerance of a New Formula Based on Hydrolyzed Rice Proteins in Children With Cow's Milk Allergy
NA · 1 location(s) · Health and Happiness Research Limited · NCT07197814Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT06842316Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
Phase N/A · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT04615988A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases
Phase 1 · 5 location(s) · BeOne Medicines · NCT07412691Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
NA · 1 location(s) · University of Virginia · NCT05653518GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases
Phase 1 · 1 location(s) · Grit Biotechnology · NCT07021209Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT06792799Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease
Phase N/A · 1 location(s) · Al-Azhar University · NCT07197099Clinical Versus Home Introduction of Milk in Children with Non-IgE-mediated Cow's Milk Allergy
NA · 1 location(s) · Martini Hospital Groningen · NCT05785299RN1201 Injection in the Treatment of Antibody-Mediated Diseases
Phase 1 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07072247QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC
Phase 2 · 1 location(s) · Anhui Provincial Cancer Hospital · NCT07330596
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.